Ledl, Andreas competitive analysis

Explore patent oppositions filed by Ledl, Andreas against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Tert Promoter Mutations In Gliomas And A Subset Of TumorsDUKE UNIVERSITYFeb 22, 2021
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEFeb 17, 2020

Latest PTAB cases involving Ledl, Andreas

Discover the latest PTAB cases involving Ledl, Andreas, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ledl, Andreas with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LEDL, ANDREAS2 - - -
DUKE UNIVERSITY - 11 - 1
F HOFFMANN LA ROCHE34231 - -
THE JOHNS HOPKINS UNIVERSITY - 22 - 23